What is acyl-CoA?
Acyl-CoA is the activated, coenzyme A–linked form of a fatty acid or other acyl group, joined through a reactive high-energy thioester bond. It is not a free fatty acid itself but its “charged” carrier form, the state in which an acyl group enters β-oxidation, lipid synthesis, and the TCA cycle. Acyl-CoA vs acetyl-CoA: acetyl-CoA is the shortest, two-carbon member of the acyl-CoA family, so all acetyl-CoA is acyl-CoA, but the broader pool also includes medium-chain, long-chain, and branched-chain species, each with a distinct fate. That difference is exactly what this review is about.
Every biochemistry course teaches acyl-CoA thioesters as intermediates, the activated carriers that move two-carbon and longer units through β-oxidation, the TCA cycle, and lipid synthesis. Read across the last year of literature, though, and a different picture emerges: the same molecules increasingly behave as control signals, setting outcomes in energy expenditure, gene regulation, disease progression, and even biomanufacturing. The unifying variable is not any one pathway but the pool itself, how much of which acyl-CoA species is available, where, and when. Here we connect four recent findings that, taken together, make that case.
01 · Energy
A thermogenic route hiding in branched-chain lipids
UCP1 is the textbook heat generator of brown and beige fat, yet UCP1-knockout mice stubbornly resist obesity, a long-standing puzzle. A 2025 Nature study resolves part of it by describing a UCP1-independent thermogenic mechanism built on the peroxisomal metabolism of monomethyl branched-chain fatty acids, whose acyl-CoA intermediates sit at the heart of the cycle. The lesson for a “pool” view of metabolism: an unusual class of acyl-CoA species, not the common straight-chain ones, can carry a distinct physiological program. Nature, 2025.
02 · Chromatin
Metabolic state, written onto the genome
If acyl-CoAs were only fuel, they would not turn up in the nucleus. But acetyl-CoA is the obligatory donor for histone acetylation, and a 2026 Molecular Metabolism study shows that feeding and fasting shift acetyl-CoA availability and, with it, histone acetylation and the transcription that governs energy storage and mobilization. The logic generalizes beyond acetyl: a Cell Metabolism study identifies ACSS2 as a lactyl-CoA synthetase that, together with KAT2A, drives histone lactylation and tumor immune evasion. Each acyl-CoA species is a potential epigenetic donor, and the enzyme that supplies it is the control point. Molecular Metabolism, 2026; Cell Metabolism, 2024.
03 · Disease & therapy
The supply line becomes the target
If the pool is a control variable, the enzymes that fill it become drug targets. In MASH-driven liver cancer, inhibiting ATP-citrate lyase (ACLY), the enzyme that makes cytosolic acetyl-CoA, did more than slow lipogenesis; it pushed the tumor toward an immunogenic state and suppressed growth (Nature, 2025). From the opposite direction, elevated malonyl-CoA promoted prostate cancer progression and castration resistance by enhancing lipogenesis and activating Ran (Cancer Research, 2025). Two cancers, two acyl-CoA species, one principle: shift the pool, shift the disease.
04 · Enzymes & engineering
The chemistry isn’t finished, and it’s a lever
The enzymology underneath keeps surprising us. Two atypical acyl-CoA dehydrogenases, ACAD10 and ACAD11, were shown to carry kinase domains that phosphorylate their own substrates, opening β-oxidation to 4-hydroxy acids otherwise incompatible with the pathway (Nature Structural & Molecular Biology, 2025). And when the pool becomes something you tune on purpose, you get bioproduction: a controllable system for intracellular malonyl-CoA in E. coli raised polyketide titers (Nature Chemical Biology, 2025).
Medium-chain acyl-CoA and the dehydrogenases that act on it
The most clinically familiar enzyme in this family is medium-chain acyl-CoA dehydrogenase (MCAD), which catalyzes the first step of β-oxidation for medium-chain (C6–C12) fatty acyl-CoA substrates. Loss-of-function mutations in its gene cause medium-chain acyl-CoA dehydrogenase deficiency (MCAD deficiency), one of the most common inherited disorders of fatty-acid oxidation. It is routinely caught on newborn screening through elevated C8 (octanoyl) acylcarnitine, and untreated it presents as hypoketotic hypoglycemia during fasting or illness, because medium-chain acyl-CoA can no longer be oxidized for fuel. The same logic extends along the chain to long-chain fatty-acid oxidation disorders, including long-chain acyl-CoA dehydrogenase deficiency and very-long-chain (VLCAD) deficiency. In every case it is a specific medium-chain acyl-CoA (or longer) species, not the size of the pool as a whole, whose handling sets the phenotype, reinforcing the theme of this review.
Read one at a time, the way most of us read, these are four separate stories in four subfields. Read together, they share one variable: the identity and concentration of acyl-CoA species.
The through-line
The acyl-CoA pool is no longer just the cell’s energy currency; it is a shared control input, read out by thermogenic machinery, chromatin-modifying enzymes, oncogenic signaling, and engineered pathways alike. For experimentalists, that reframing has a practical edge. If the pool is the signal, then measuring it accurately, and supplying the right species in the right form, is not a detail. It is the experiment.
How does acyl-CoA cross the inner mitochondrial membrane?
Long-chain fatty acyl-CoA cannot diffuse across the inner mitochondrial membrane on its own. It is handed to the carnitine shuttle: CPT1 converts long-chain acyl-CoA to acylcarnitine for transport into the matrix, and the rate of that step is throttled by malonyl-CoA. When malonyl-CoA is high (the fed state) the gate closes and acyl-CoA is held in the cytosol; when malonyl-CoA falls (the fasted state) the gate opens and β-oxidation runs. Short- and medium-chain acyl-CoAs bypass CPT1 altogether, they have no gate to clear.
What this means at the bench
Acyl-CoA thioesters are reactive: the high-energy thioester bond hydrolyzes under sub-optimal pH, temperature, or freeze–thaw, and CoA’s free thiol is oxidation-prone. How a vial is reconstituted and stored changes the real substrate concentration your assay receives, a quiet driver of run-to-run variance in exactly the pool-sensitive experiments above.
Read the handling & reconstitution protocol
In the cell, each of these thioesters is the product of an acyl-CoA synthetase reaction, the enzyme class that activates free fatty acids to their CoA thioesters, so starting from a purified, defined acyl-CoA lets you bypass that activation step at the bench. Because biology increasingly hinges on specific species, odd- and branched-chain, malonyl, lactyl, and beyond, access to the right counter-ion form matters too. Our catalog covers 94 acyl-CoA thioesters in sodium-salt, lithium-salt, and free-acid forms. Browse the Coenzyme A & Acyl-CoA collection →
References
Source: PubMed (U.S. National Library of Medicine). Primary sources linked by DOI.
- Peroxisomal metabolism of branched fatty acids regulates energy homeostasis. Nature, 2025. doi.org/10.1038/s41586-025-09517-7
- Nutrient-driven histone acetylation underlies energy storage and mobilization. Molecular Metabolism, 2026. doi.org/10.1016/j.molmet.2026.102344
- ACSS2 acts as a lactyl-CoA synthetase and couples KAT2A to function as a lactyltransferase for histone lactylation and tumor immune evasion. Cell Metabolism, 2024. doi.org/10.1016/j.cmet.2024.10.015
- ACLY inhibition promotes tumour immunity and suppresses liver cancer. Nature, 2025. doi.org/10.1038/s41586-025-09297-0
- Malonyl-CoA promotes prostate cancer progression and castration resistance by enhancing lipogenesis and Ran activation. Cancer Research, 2025. doi.org/10.1158/0008-5472.CAN-24-4247
- ACAD10 and ACAD11 enable mammalian 4-hydroxy acid lipid catabolism. Nature Structural & Molecular Biology, 2025. doi.org/10.1038/s41594-025-01596-4
- Engineering controllable alteration of malonyl-CoA levels to enhance polyketide production. Nature Chemical Biology, 2025. doi.org/10.1038/s41589-025-01911-6